0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Black Diamond Therapeutics Inc - Trending symbols

Notifications

TypeNotificationDate
RSI OversoldOversold RSI (Relative Strength Index)2024-11-21



Trends

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Accumulated Other Comprehensive Income -364337-27-68-95-20-115222107
Long-term Assets Other 1,168601,228-4098194823-8230
Total Stockholder Equity 196172,364172,560-20,189152,371-19,140133,231-468,220-334,989
Liabilities and Stockholders Equity 248219,234219,482-20,648198,834-18,418180,416-474,845-294,429
Reconciled Depreciation 123212531281129-510-381
Depreciation and Amortization 123212531281129-2,361-2,232
EBIT -26,080979-25,1012,557-22,5441,452-21,09291,09270,000
Operating Income -26,080401-25,6792,506-23,1731,049-22,12493,00770,883
Total Other Income Expense Net 125,683-125,51117271243227470-1,353-883
Research Development 17,7565,06422,8203,89926,71990727,626-104,694-77,068
Income before Tax -22,626-7,675-30,301-4,050-34,351-726-35,077134,68099,603
Net Income -22,626-7,675-30,301-4,050-34,351-726-35,077134,68099,603
Selling General Administrative 5,4272,4667,8931037,996-2587,738-31,335-23,597
EBITDA -22,611-8,083-30,694-3,637-34,331-703-35,034135,699100,665
Total Operating Expenses 23,1837,53030,7134,00234,71564935,364-136,029-100,665

Comments

How you think about this?

Leave a comment

Stay informed about Black Diamond Therapeutics Inc.

Receive notifications about Black Diamond Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.